United States· US:63102-402_abf1349b-a08e-4236-9b32-42a0e76e78a9
ACTIDOGESIC
A medicinal product containing dexbrompheniramine maleate; acetaminophen, registered in United States by ACTIPHARMA, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEXBROMPHENIRAMINE MALEATE; ACETAMINOPHEN
- Manufacturer
- ACTIPHARMA, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1163102-402-10
- ndc116310240210100 TABLET in 1 BOTTLE (63102-402-10)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa608fc5-a2b0-4cbb-b73f-5dd9e1193be2 GET /v1/drugs/aa608fc5-a2b0-4cbb-b73f-5dd9e1193be2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1; 500",
"substance": "DEXBROMPHENIRAMINE MALEATE; ACETAMINOPHEN",
"productndc": "63102-402",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "M012",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about dexbrompheniramine maleate; acetaminophen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.